The 20th May is International Clinical Trials Day - celebrating the birth of clinical trials back in 1747. Read More

This book explores the use of Positive Ventilation Delivery Systems for intubated ICU patients to detect Pulmonary Embolism. PE is responsible for more deaths than any other single disease, yet it is often under diagnosed. Read More

Working Together on Next-Generation Medicines for Patient Benefit London, April 10 2013 - The Cell Therapy Catapult (CT Catapult), which is focused on the development of the UK cell therapy industry to increase the nation's health and wealth, and the UK Stem Cell Foundation, a charity focused on the advancement of stem cell treatments towards the clinic, are pleased to announce that they will be working together to progress promising stem cell-based therapies in the UK. Read More

Patent expirations  and the accompanying lost revenue  place great strain on all areas of the company. Much of that burden falls to clinical development teams charged with ushering investigational medicines to market. Phase I is an important step for investigational compounds on the journey to regulatory Patent expirations  and the accompanying lost revenue  place great strain on all areas of the company. Much of that burden falls to clinical development teams charged with ushering investigational medicines to market. Phase I is an important step for investigational compounds on the journey to regulatory approval Read More

Most drug & device clinical trial executives in biopharmaceutical & medical device enterprises are starting to become aware of FDA's new guidance on risk-based monitoring. However, many drug & device clinical trial personnel are still unclear about what the FDA guidance means in their drug & device clinical trials, and how they could efficiently implement risk-based monitoring practices. This article will provide brief recommendations on how to fully leverage FDA's new guidance document in clinical trial monitoring. Read More

A consortium of 10 UK government and charity funders, led by the Medical Research Council (MRC), has made a historic £19 million investment to establish four e-health research Centres of Excellence Read More

Under the new rules proposed, the EU would move to a harmonized, EU-wide approach to clinical trials registration. The 2001 Clinical Trials Directive would be scrapped and replaced with an EU-wide regulation. Read More

SCOTLANDS life sciences companies were given a boost yesterday as building work got under way for a centre in Dundee to bring together academics and industrialists, which will initially create 200 research jobs. The £12.5 million Centre for Translational & Interdisciplinary Research (CTIR) will house more than 1,000 scientists and support staff when it opens next year and is expected to attract drugs developers and other firms. Read More

New UK Guidance on UK Phase I Clinical trials published. The guidance is intended for use by Phase I clinical trial sponsors, clinical research organisations and ethics committees. It has been developed to provide authoritative recommendations on the level of insurance and other aspects of insurance cover. The guidance is based on industry best practice and complements wider industry guidance on conducting Phase I clinical studies. Read More

Supreme Court Ruling Generates Widespread Reaction at the DIA 2012 Annual Meeting PHILADELPHIA, PA, USA  June 28, 2012 Read More

This report examines the role played by intellectual property rights in both upstream and downstream phases of the research, development and commercialization of biotechnology products... Read More

Ann Meeker-OConnell, Acting Associate Director of Risk Science, Intelligence & Prioritization, FDA says - A sponsor has to indicate what specific responsibilities they are transferring to the CRO in writing. Meeker-OConnell gives her thoughts in a video interview with Outsourcing Pharma at the 2011 DIA meeting. Read More

19 out of 21 pharmaceutical companies surveyed by Cutting Edge Information ranked a contract research organisation's ability to hit trial deadlines as either "extremely important" or very "important," making it the top quality identified by respondents. Read More

Good news for scientists with a £100 million boost in spending on capital projects as well as promised removal of red tape surrounding biomedical research and clinical trials. Read More

The University of Dundee/NHS Tayside is one of the key locations of the world's first national breast cancer tissue bank. Read More

Onorach Ltd. has recently signed a partnership agreement with CliniWorks Inc. to distribute their AccelFind patient recruitment application in the UK and Ireland. Read More

The U.S. Food and Drug Administration today unveiled a plan containing 25 actions it intends to implement during 2011 to improve the most common path to market for medical devices. Read More

Onorach™ Clinical is pleased to announce that it will be presenting at the TB Drug Discovery Conference in Glasgow, UK, on 22-23 November 2010. Jan Anderson, Onorach's clinical / QA operations manager, will be presenting. Professor Christene Leiper, managing director and president, as well as Stephen Leiper, CEO of Onorach Clinical, will also attend the conference. TBD-UK has invited Onorach Clinical to present at the two-day conference, which will focus on developing potential new projects, forging new partnerships and an agreement on what actions need to be taken Read More

Clinical Research Explained * What is a Clinical Trial? * Introduction to Translational Medicine and Clinical development Janice Anderson, BS, MAOM, Clinical Project Manager, Onorach Ltd. An Introduction to Good Clinical Practice * An introduction to the ethical and scientific quality standards in clinical Read More

Professor Christene Leiper and Mr Stephen Leiper recently completed an advanced International Preparedness Programme Read More

Professor Christene Leiper has published an article on 'Effective Site Management' in Next Generation Pharma Magazine (US). Read More